Lung Transplant Failure and Rejection Clinical Trial
Official title:
Long Term Follow up of the Lung Transplant Outcomes Group Cohort
The purpose of the study is to follow participants who enrolled in the Lung Transplant Outcomes Group. Clinical data, functional assessments, and surveys will be collected to determine long term graft function and functional status of lung transplant recipients.
This project will involve both retrospective and prospective data collection from participants enrolled in the LTOG cohort studies. We will perform long-term Chronic Lung Allograft Dysfunction (CLAD) phenotyping of lung transplant recipients who participated in the LTOG cohort studies utilizing data collected for routine clinical visits. Surviving lung transplant recipients who participated in the LTOG cohort studies will be recruited to enroll in the longitudinal portion of the project. The longitudinal component will include follow-up data collection at 6 month intervals while alive until study termination, study withdrawal, or no longer being seen for follow-up at the participating center. Follow-up data collection will include clinical data collected by study coordinators by reviewing medical records, functional assessment through administration of the Short Physical Performance Battery (SPPB), blood collection and surveys. Data from this project will be linked to data and samples collected during the LTOG cohort or ancillary studies. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05050955 -
AlloSure Lung Assessment and Metagenomics Outcomes Study
|
||
Terminated |
NCT04558333 -
CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation
|
||
Recruiting |
NCT05006742 -
Comparison of Transbronchial Cryobiopsy and Forceps Biopsy in Lung Transplant Recipients
|
N/A | |
Active, not recruiting |
NCT03656926 -
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)
|
Phase 3 | |
Recruiting |
NCT04837339 -
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
|
N/A | |
Terminated |
NCT04318587 -
Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation
|
N/A | |
Enrolling by invitation |
NCT05934617 -
Trajectories of FEV1 After Lung Transplantation
|
||
Active, not recruiting |
NCT04126746 -
Clinical Trials in Organ Transplantation Extension Study
|
||
Active, not recruiting |
NCT03657342 -
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
|
Phase 3 |